Continuous 72-h infusion of zosuquidar with chemotherapy in patients with newly diagnosed acute myeloid leukemia stratified for leukemic blast P-glycoprotein phenotype
Cancer Chemotherapy and Pharmacology · 2024
DOI: 10.1007/s00280-024-04656-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2024. Verfasst von John F Marcelletti und 1 weiteren Autor:innen. Beteiligte Einrichtung: Marcelletti Consulting, San Diego, CA, USA. jfmphd@yahoo.com. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Cytarabine, Daunorubicin, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: NIH HHS, NCI NIH HHS, Kanisa Pharmaceuticals, San Diego, CA, USA.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Marcelletti Consulting, San Diego, CA, USA. jfmphd@yahoo.com.
- Clinical and Translational Research Unit, Stanford Cancer Institute, Stanford, CA, USA.
ORCID-Profile: John F Marcelletti, Branimir I Sikic
Förderung
- NIH HHS
- NCI NIH HHS
- Kanisa Pharmaceuticals, San Diego, CA, USA
- NIH
Zitieren
APA
Marcelletti, J. F., & Sikic, B. I. (2024). Continuous 72-h infusion of zosuquidar with chemotherapy in patients with newly diagnosed acute myeloid leukemia stratified for leukemic blast P-glycoprotein phenotype. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04656-6
Vancouver
Marcelletti JF, Sikic BI. Continuous 72-h infusion of zosuquidar with chemotherapy in patients with newly diagnosed acute myeloid leukemia stratified for leukemic blast P-glycoprotein phenotype. Cancer Chemotherapy and Pharmacology. 2024. doi:10.1007/s00280-024-04656-6
BibTeX
@article{Marcelletti2024,
author = {Marcelletti, John F and Sikic, Branimir I},
title = {Continuous 72-h infusion of zosuquidar with chemotherapy in patients with newly diagnosed acute myeloid leukemia stratified for leukemic blast P-glycoprotein phenotype},
journal = {Cancer Chemotherapy and Pharmacology},
year = {2024},
doi = {10.1007/s00280-024-04656-6}
}
EUVIMED